Implementation of contingency plans allows for continued progress in therapy development
Get updates from the Cell Lines Blog delivered to your inbox.
Why a diverse apheresis center network is critical to business continuity
Are ‘super donors’ the answer to sustainable growth for the allogeneic cell and gene therapy industry?
Why reliance on a small subset of donors could introduce risk for companies
Why established systems and relationships matter
An expert opinion on HLA matching relevance for allogeneic cell therapies
By Jamie Margolis, PhD, Senior Vice President of Donor Services, NMDP/Be The Match
A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies
Design a tailored logistics plan to deliver